Form D · Other Health Care

MEDIVANCE INC

Louisville, CO · CIK 0001116451

Offering snapshot reported Jul 9, 2009 · SEC filing

Reported sold
$8.07M
Offering amount: $11.8M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 25, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 9, 2009Initial$8,070,000No comparison17SEC filing
Aug 13, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 9, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 27, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-77784
The securities sold were Preferred Stock and Warrants to Acquire Preferred Stock. The total remaining amount to be sold represents the gross dollar value (based upon exercise price)of the Preferred Stock underlying the Warrants

Source: Form D, filed Jul 9, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joanne Bauer Director
Gary Carson Executive
Karen Cassidy Director
John Cassis Director
John Freund Director
Robert Holburn Executive
Richard Johnston Director
Robert Kline Director, Executive
Gene Mc Grevin Director
Sallie Shuping Russell Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
321 South Taylor Avenue Suite 200
Louisville, CO, 80027